LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $10.2M invested in LAVA Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 22 → 20 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
20
Holding in Top 10
2
Calls
$68K
Puts
–
Top Buyers
| 1 | +$2.49M | |
| 2 | +$30.9K | |
| 3 | +$29.2K | |
| 4 |
Two Sigma Investments
New York
|
+$11.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.38K |
Top Sellers
| 1 | -$318K | |
| 2 | -$98.9K | |
| 3 | -$30.4K | |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$20.5K |
| 5 |
VF
Virtu Financial
New York
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – |
|
|||
27
CIBC Private Wealth Group
Atlanta,
Georgia
| – |
|
|||
28
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – |
|